Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBNP for coronary microvascular function after rotational atherectomy
ChiCTR2600130272Phase 3Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Coronary Small Vessel Disease (CMD) and coronary arteriosclerosis comparing Experimental group (rhBNP) with Control group (saline placebo) (2 arms). Primary endpoints: Preoperative Angio-IMR and Postoperative Angio-IMR. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
nesiritide
03
Conditions
Coronary Small Vessel Disease (CMD)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2600130272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130272.